查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1620517

神经肌肉电刺激器市场机会、成长驱动因素、产业趋势分析和 2024 年至 2032 年预测

Neuromuscular Electric Stimulator Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 134 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球神经肌肉电刺激器市值为3.817 亿美元，预计2024 年至2032 年复合年增长率为9.1%。刺激器的需求不断增长推动的。在便携式神经肌肉刺激器创新的推动下，向个人化和家庭治疗的转变进一步推动了市场向前发展。现代设备现在提供无线技术和可自订的程序，使其更容易满足个人治疗需求。领先卫生机构的监管批准也促进了市场的成长，增强了消费者的信任和采用。

就产品类型而言，市场分为手持式和穿戴式神经肌肉刺激器。 2023 年，手持刺激器的收入最高，达 3.098 亿美元。这些设备因其方便和易于使用而受到青睐，特别是对于寻求非侵入性家庭治疗关节炎和运动相关损伤等疾病的患者而言。手持式刺激器的紧凑设计使其比大型固定设备更受欢迎。

在检视最终用途领域时，市场分为医院、復健中心、家庭护理机构、运动诊所和门诊手术中心。医院在 2023 年引领市场，预计到 2032 年将产生 3.21 亿美元的收入。中风、多发性硬化症和脊髓损伤等慢性疾病的发病率不断上升，增加了对先进復健工具的需求，进一步推动了它们在医院环境中的采用。北美神经肌肉电刺激器市场2023 年收入为1.573 亿美元，预计2024 年至2032 年复合年增长率为8.4%。 这种增长是由于人们对运动医学和健身復健（尤其是运动员）的日益关注所推动的随着人们对运动相关伤害及其治疗的认识不断增强，神经肌肉刺激器在该地区的诊所和训练设施中得到越来越广泛的采用。 。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 3.817 亿美元
预测值 8.392 亿美元
复合年增长率 9.1%

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • NMES 技术的技术进步
      • 对非侵入性治疗方案的需求不断增长
      • 更加重视预防保健
    • 产业陷阱与挑战
      • 不良反应的风险
  • 成长潜力分析
  • 监管环境
  • 报销场景
  • 技术景观
  • 程序见解，（2021 -2032）
    • 膝关节置换手术
    • 髋关节置换手术
    • 踝关节置换手术
  • 临床应用场景
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势
  • 差距分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032

  • 主要趋势
  • 手持式神经肌肉刺激器
  • 穿戴式神经肌肉刺激器

第 6 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 疼痛管理
  • 肌肉復健
  • 术后恢復
    • 膝关节置换术后康復
    • 髋关节置换术后恢復
    • 踝关节置换恢復
  • 运动医学

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 復健中心
  • 家庭护理设置
  • 运动诊所
  • 门诊手术中心

第 8 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 9 章：公司简介

  • AxioBionics LLC
  • Enovis Corporation
  • Ibramed Medical
  • MTR + Vertriebs GmbH
  • NeuroMetrix, Inc.
  • OMRON Corporation
  • Ottobock
  • RS Medical
  • Sky Medical Technology Ltd.
  • Verity Medical Ltd.
  • Zynex, Inc.
简介目录
Product Code: 11802

The Global Neuromuscular Electric Stimulator Market was valued at USD 381.7 million in 2023 and is projected to grow at 9.1% CAGR from 2024 to 2032. This growth is primarily driven by technological advancements, the increasing prevalence of musculoskeletal disorders, and a rising demand for effective rehabilitation solutions. The shift towards personalized and home-based treatments, fueled by innovations in portable neuromuscular stimulators, further propels the market forward. Modern devices now offer wireless technology and customizable programs, making them more accessible for individual therapy needs. Regulatory approvals from leading health agencies have also contributed to the market's growth, enhancing consumer trust and adoption.

In terms of product types, the market is segmented into handheld and wearable neuromuscular stimulators. In 2023, handheld stimulators generated the highest revenue, reaching USD 309.8 million. These devices are favored for their convenience and ease of use, especially for patients seeking non-invasive, at-home treatments for conditions like arthritis and sports-related injuries. The compact design of handheld stimulators makes them preferable over larger, stationary devices.

When examining end-use sectors, the market is divided into hospitals, rehabilitation centers, home care settings, sports clinics, and ambulatory surgical centers. Hospitals led the market in 2023 and are expected to generate USD 321 million by 2032. As primary providers of treatment for musculoskeletal conditions and post-surgical recovery, hospitals are major users of neuromuscular electric stimulators. The rising incidence of chronic illnesses, such as stroke, multiple sclerosis, and spinal cord injuries, has increased the demand for advanced rehabilitation tools, further driving their adoption in hospital settings. The North American neuromuscular electric stimulator market accounted for USD 157.3 million in revenue in 2023 and is anticipated to grow at a CAGR of 8.4% from 2024 to 2032. This growth is fueled by an increasing focus on sports medicine and fitness rehabilitation, particularly among athletes and fitness enthusiasts.As awareness of sports-related injuries and their treatments grows, neuromuscular stimulators are becoming more widely adopted in clinics and training facilities across the region. .

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$381.7 Million
Forecast Value$839.2 Million
CAGR9.1%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancements in NMES technologies
      • 3.2.1.2 Growing demand for non-invasive treatment options
      • 3.2.1.3 Increasing focus on preventive care
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risk of adverse effects
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Technology landscape
  • 3.7 Procedure insights, (2021 -2032)
    • 3.7.1 Knee replacement procedures
    • 3.7.2 Hip replacement procedures
    • 3.7.3 Ankle replacement procedures
  • 3.8 Clinical applications scenario
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis
  • 3.11 Future market trends
  • 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major key players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Handheld neuromuscular stimulators
  • 5.3 Wearable neuromuscular stimulators

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Pain management
  • 6.3 Muscle rehabilitation
  • 6.4 Post-surgical recovery
    • 6.4.1 Knee replacement recovery
    • 6.4.2 Hip replacement recovery
    • 6.4.3 Ankle replacement recovery
  • 6.5 Sports medicine

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Rehabilitation centers
  • 7.4 Home care settings
  • 7.5 Sports clinics
  • 7.6 Ambulatory surgical centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 AxioBionics LLC
  • 9.2 Enovis Corporation
  • 9.3 Ibramed Medical
  • 9.4 MTR + Vertriebs GmbH
  • 9.5 NeuroMetrix, Inc.
  • 9.6 OMRON Corporation
  • 9.7 Ottobock
  • 9.8 RS Medical
  • 9.9 Sky Medical Technology Ltd.
  • 9.10 Verity Medical Ltd.
  • 9.11 Zynex, Inc.